Harvard Medical School researchers call for a reinvigoration of the Park doctrine holding corporate officers personally liable for misconduct by drug ...
FDA warns Scottsdale, AZ-based BioLab Sciences it is illegally marketing drug and biologic products that have been produced with significant CGMP viol...
FDA medical reviewers tell the Oncologic Drugs Advisory Committee there are significant questions about Spectrum Pharmaceuticals proposed lung cancer ...
FDA reviewers say that a confirmatory trial has not confirmed the clinical benefit of Oncopeptides Pepaxto (melphalan flufenamide), throwing into ques...
The Alliance for Regenerative Medicine and Pfizer suggest changes to an FDA draft guidance on real-time oncology review.
CDER Office of Generic Drugs associate director Sarah Ibrahim discusses the first-year output of the new Generic Drug Cluster involving several regula...
FDA issues a safety alert on a cybersecurity risk with Medtronics MiniMed 600 Series Insulin Pump System (e.g., MiniMed 630G and MiniMed 670G).
Federal Register notice: FDA seeks patient advocate applications to participate under its collaboration with the Clinical Trials Transformation Initia...
